comparison of glp 1 receptor agonists Comparing Ozempic, Wegovy and Other GLP-1 Drugs VisualAbstract: Glucagon-like peptide 1 receptor
Description
By 2030 the impact of widespread use on addressing the global Obesity crisis should be apparent
Data curation
Schwenk, R
Srensen MB, Rosenfalck AM, Hjgaard L, Ottesen B
Trials with fewer than 50 participants per arm and those reporting outcomes solely regarding risk or hazard ratios without exact outcome figures were excluded from the meta-analysis
